Besides Lilly (NYSE: LLY) reporting earnings this morning there was a grab bag of other wacky news. So, let’s get to it-
First and we just love this one Johnson and Johnson (NYSE: JNJ) sent out an email today which stated;
“As diabetes prevalence continues to rise, two recent studies in the Journal of Diabetes Science and Technology show that blood-based self-monitoring methods, such as the OneTouch Verio Flex® blood glucose monitoring system, remain the most accurate and cost effective way to monitor blood glucose levels – as newer technology comes up short on both points. “
Now . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.